toll-like receptor modulator (Opsona/Pfizer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nametoll-like receptor modulator (Opsona/Pfizer)
Drug Alias NameTLR modulators (Opsona/Wyeth)toll-like receptor modulator (Opsona/Wyeth)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll-like receptor modulators
TargetsToll-like receptor
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpsona Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Pharmaceuticals CoOpsona Therapeutics LtdPfizer Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A